The Delhi Directorate General of Health Services has asked all chief district medical officers, medical directors, and ...

Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...

Human Metapneumovirus HMPV is a respiratory virus that can cause cold-like symptoms to severe infections like pneumonia Learn ...

Introduction Acute exacerbation of interstitial lung disease (AE-ILD) often results in death and poses significant challenges in clinical management. While corticosteroids are frequently employed, the ...

An acute stroke, like most forms of stroke, starts suddenly and worsens rapidly. Some strokes may be preceded by a transient ischemic attack (TIA), a temporary stroke that resolves before causing any ...

Xolair (omalizumab) is a prescription drug used to treat certain conditions, such as asthma or food allergies. The drug comes as an injection. It’s usually given once every 2 or 4 weeks.

Acute pericarditis is a condition in which inflammation occurs in the pericardium, the fluid-filled sac that surrounds the heart. “Acute” means the condition develops quickly or suddenly. The ...

Chronic bronchitis is a common disease in elderly patients. Acute exacerbation of chronic bronchitis (AECB) is a common feature of chronic obstructive pulmonary disease. Antibiotic therapy based ...

“Severe” AQI levels signify hazardous air quality for everyone, posing serious health risks even for healthy individuals. For individuals with chronic respiratory conditions like COPD, asthma, ...

Bronchitis is a condition that mostly affects the upper airway. Caused by infection or irritation, acute bronchitis can usually resolve on its own over the course of a few weeks. Both bronchitis ...

Background Evidence regarding high-dose inhaled corticosteroids (HDICS) in asthma exacerbations in adults is insufficient. This study compares the treatment outcomes of HDICS as add-on therapy to the ...